AstraZeneca vaccine gets FDA nod for emergency use

THREE weeks after submitting its application, the Food and Drug Administration (FDA) has finally given the British pharma company AstraZeneca an emergency use authorization (EUA) for its COVID-19 vaccine.

“After a thorough review of the currently available data by our medical and regulatory experts, the FDA is granting an emergency use authorization to the COVID-19 vaccine AstraZeneca,” FDA Director General Eric Domingo said during a Laging Handa briefing.

AstraZeneca’s vaccine is the second to have been given an EUA by the government following the Pfizer-BioNTech vaccine.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.